In analysis of more than 20,000 patients, bariatric surgery produced greatest weight loss at 2 years, followed by switching between GLP-1 medications and switching to a non-GLP1 medication
New space expands access to nutrition education, healthy cooking skills and food resources at the Langston Hughes Community Health & Education Center
A year of fundraising and generosity accelerates search for a cure through VeloSano, a Cleveland Clinic global fundraising movement to end cancer
Larger location expands access to Cleveland Clinic’s global expertise, advanced diagnostics and personalized care
One-time treatment reduced triglycerides by nearly 65% after 30 days
ARO-DIMER-PA is a Dual-Target RNA Therapy that targets the liver to lower two key proteins involved in high cholesterol at the same time
Phase 3 HORIZON cardiovascular outcome trial examined the safety and efficacy of pelacarsen in patients with elevated lipoprotein(a) and pre-existing cardiovascular disease
Patients achieved meaningful two-year weight loss after undergoing bariatric surgery
Cleveland Clinic earned Newsweek's new Leader in AI Innovation Distinction